Propel Success: Eubiotics Market Navigates US$ 5.47 Billion...

Propel Success: Eubiotics Market Navigates US$ 5.47 Billion Trajectory

Posted 2024-05-10 07:11:51

587

As per Future Market Insights (FMI) analysis, the global consumption of eubiotics increased by a year-on-year (YoY) rate of 6.7% in 2021 to total sales of US$ 2.68 Billion in the year. The overall demand for eubiotics represents 16.4% of the global animal feed market in 2021 and is poised to increase at 7.4% CAGR to reach a value of US$ 5.47 Billion in 2031.

controlling the rise of AMR (anti-microbial resistance) products at the global level.

According to research, almost 70% of the antibiotics used worldwide, are considered medically important for the livestock sector, but the application varies for each country and species of the farmed animal. Usage of antibiotics is considerably high in swine, on average, which is followed by poultry and ruminants. Though some of the manufacturers are no longer using AGPs (antibiotic growth promotors), instead of going for sustainable alternatives like eubiotics.

The EU Commission banned the use of (antibiotic growth promotors) in 2006, limiting the prophylactic use of antibiotics in farmed animals. The British Poultry Council as well, in 2017, adopted a voluntary ban on excessive use of AGPs, which was representing 90% of the broiler production in the UK.

Discover a detailed summary of the report, encompassing market size, forecast, and research methodology. Access the sample report in PDF format: https://www.futuremarketinsights.com/reports/sample/rep-gb-11087

This trend has increasingly spread across the globe since the EU leading the way back in 2006, followed by South Korea and Indonesia recently, as well as the FDA (US Food and Drug Administration) put to notice and discouraged the (antibiotic growth promotor) use.

Since eubiotics, such as prebiotics, probiotics, enzymes, and organic acids, can add the essential nutritional components to reduce the antibiotic use in farmed animals that can enable the industry to grow further. Key manufacturers like DSM are developing effective eubiotics solutions to reduce the prophylactic use of antibiotics and to remove AGPs to tackle AMR, to switch to antibiotic-free animal diets smoothly over time.

Key Takeaways from the Eubiotics Market Study:

North American eubiotics market lead in terms of market share and accounts for 31.1% of the global eubiotics market in 2021 exhibiting high demand for the product with the presence of leading manufacturers in the region.
Organic acid is the dominant type of eubiotics having more antimicrobial and preservative effects as compared to other types of eubiotics. Organic acid accounts for a market share of 48.3% in 2021 of the global market.
In the form segment, the liquid form is anticipated to witness a lucrative growth rate with a CAGR of 7.8% during the forecast period (2021-2031) for the eubiotics market.
By function, nutrition and gut health is accounted for 37.9% of the total market share in 2021, while the segment is also expected to witness a lucrative growth rate of 7.5% during the forecast period.

In the livestock segment, aquaculture is anticipated to witness a lucrative growth rate with a CAGR of 8.1% during the forecast period (2021-2031) in the eubiotics market.

“The top manufacturers in the eubiotics market in emerging countries are increasingly inclined towards new innovative technologies for better and efficient product development with sustainable and effective solutions to antibiotics. This factor is owing to the high demand for eubiotics, shooting up the adoption of the product in the global market.” According to a lead analyst at FMI.

Purchase this Premium Research Report | Immediate Delivery Available:
https://www.futuremarketinsights.com/checkout/11087

Who is winning?

According to the Veterinary Medicines Regulation, published on December 11, 2018, the regulatory body has identified the need to control use of antimicrobial farm animal products and has put a ban on the prophylactic and metaphylactic antimicrobials usage in animals. The regulation will come into effect from January 28, 2022, forcing the manufacturers to convert the antibiotic based products into sustainable alternatives like eubiotics.

Some of the leading companies offering eubiotics are Cargill Inc., BASF SE, Koninklijke DSM N.V., Novozymes, Eubiotics, Lesaffre Group, Kemin Industries, Inc., Novus International, Inc., Chr. Hansen Holding A/S, Beneo Group, and others.

By Type, eubiotics is segmented as: